Results 311 to 320 of about 558,195 (361)
Some of the next articles are maybe not open access.
Bone marrow biopsy in malignant disease
Postgraduate Medicine, 1974Bone marrow examination should routinely include biopsy. Often it is the only means of detecting advanced malignant disease. The findings aid in determining therapy and sometimes in following therapeutic response.
openaire +2 more sources
Bone Marrow Transplantation for Nonmalignant Diseases
Journal of Hematotherapy & Stem Cell Research, 2002Bone marrow transplantation (BMT) has emerged as a major therapeutic option for a number of nonmalignant disorders affecting the bone marrow and leading to clinical manifestations most likely affecting distant organs. Disorders such as autoimmune diseases, metabolic disorders, hemoglobinopathies, immunodeficiencies, and others have been the target of ...
Nabil, Saba, Thomas, Flaig
openaire +2 more sources
Megaloblastic bone marrow in liver disease
The American Journal of Medicine, 1949Abstract Cirrhosis of the liver accompanied by severe macrocytic anemia constitutes another disease entity which can be added to the list of conditions associated with megaloblastic proliferation in the bone marrow. ∗ ∗Since submission of this manuscript for publication, another case of cirrhosis of the liver with megaloblastic anemia has come under ...
openaire +2 more sources
Bone Marrow Scintigraphy in Paget's Disease of Bone
Acta Radiologica, 1990Sixteen patients with 20 lesions of Paget's disease of bone were studied with bone marrow scintigraphy (colloid), bone tissue scintigraphy and radiography. Bone marrow scintigraphy showed normal or increased colloid uptake in 15 of 20 pagetic lesions, and decreased uptake in 4.
U, Rudberg, S O, Ahlbäck, R, Udén
openaire +2 more sources
Bone Marrow Transplantation for Autoimmune Diseases
Acta Haematologica, 1998Bone marrow transplantation (BMT) is now becoming a powerful strategy for the treatment of patients with autoimmune diseases. Using various animal models for autoimmune diseases, we have previously found that allogeneic BMT (not autologous BMT) can be used to treat autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA)
openaire +2 more sources
Bone Marrow Transplantation for Non-Malignant Disease
Hematology, 2000AbstractThis article reviews the experience in hematopoietic stem cell transplantation (HSCT) for non-malignant disease. HSCT has long been applied as treatment of life-threatening congenital immunodeficiency and metabolic diseases. In Section I, Dr. Parkman reviews that experience for severe combined immunodeficiency, Wiscott-Aldrich syndrome, hyper ...
Keith M., Sullivan +2 more
openaire +3 more sources
Intractable diseases and bone marrow transplantation
Pathology International, 1994Intractable diseases are defined as diseases of unknown etiopathogenesis, and for which therapeutic strategies remain to be established. They are therefore likely to cause various sequelae. Of the 86 intractable diseases recognized by the Ministry of Health and Welfare of Japan, half are thought to be curable by bone marrow transplantation (BMT).This ...
openaire +2 more sources
Bone marrow transplants in genetic diseases
European Journal of Pediatrics, 1992The first paper [9] advocating the displacement use of bone marrow transplantation (DBMT) to treat a variety of genetic metabolic diseases (including thalassaemia major) was put before a European Working Party in 1978. It evolved from mainly Westminster experience which showed the need [6] for DBMT and first successfully used donors other than matched ...
openaire +2 more sources
Bone Marrow Transplantation for Sickle Cell Disease
New England Journal of Medicine, 1996We investigated the risks and benefits of allogeneic bone marrow transplantation in children with complications of sickle cell disease.Twenty-two children less than 16 years of age who had symptomatic sickle cell disease received marrow allografts from HLA-identical siblings between September 1991 and April 1995.
M C, Walters +11 more
openaire +2 more sources
Bone Marrow Transplantation Symposium: Bone Marrow Transplantation for Immunodeficiency Diseases
The American Journal of the Medical Sciences, 1987Allogeneic bone marrow transplantation (BMT) was applied in 1968 to treat severe combined immunodeficiency disease (SCID). Almost simultaneously, marrow from an MHC-matched donor corrected the immunological deficiency of a patient with Wiscott-Aldrich Syndrome (WAS).
openaire +1 more source